Alyftrek 4-20-50 MG tablet 21S
Ended Awarded
- Contract number
- SPE2DB25FX2DL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,993
Award facts
- Contract value 100% obligated
- $20,993.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,993.31 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alyftrek 4-20-50 mg tablets (21-count packages). This firm fixed-price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program valued at $499.999 billion and valid through November 2026, which serves as the underlying vehicle for this delivery order.
DMS Pharmaceutical Group specializes in distributing a comprehensive range of pharmaceutical products to federal agencies and military healthcare facilities nationwide, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The company has established itself as a critical supplier within the federal pharmaceutical supply chain through its contract portfolio with the DLA, which encompasses an extensive array of medical products ranging from contraceptive devices to oncology treatments and specialty medications. This delivery order represents a routine pharmaceutical replenishment supporting the Defense Logistics Agency's medical supply requirements for Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FX2DL?
SPE2DB25FX2DL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FX2DL worth?
The government has obligated $20,993 on SPE2DB25FX2DL.
Is contract SPE2DB25FX2DL an order under another contract?
Yes. SPE2DB25FX2DL is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2DL competed?
The extent of competition for SPE2DB25FX2DL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award